Clinical Trial Update: Anticholinergic Deprescription in Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating anticholinergic deprescription strategies in individuals with schizophrenia or schizoaffective disorder; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Deepak K. Sarpal, M.D. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: RECRUITING